Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 2.52 | 22.53 | 23.60 | 7.34 |
Depreciation/ Depletion | 0.65 | 0.64 | 0.59 | 0.49 |
Non- Cash Items | -0.62 | 1.01 | 0.59 | 1.21 |
Changesin Working Capital | 6.86 | -33.62 | -7.31 | -4.21 |
Cashfrom Operating Activities | 9.41 | -9.44 | 17.47 | 4.83 |
Capital Expenditures | -0.67 | -1.36 | -1.28 | -2.73 |
Other Investing Cash Flow Items Total | 0.26 | -1.65 | 0.21 | -0.19 |
Cashfrom Investing Activities | -0.41 | -3.01 | -1.06 | -2.92 |
Financing Cash Flow Items | -0.69 | -1.23 | -0.67 | -1.27 |
Total Cash Dividends Paid | -0.31 | -0.31 | 0.00 | - |
Issuance( Retirement)of Debt Net | -10.20 | 11.14 | -1.27 | -0.62 |
Cashfrom Financing Activities | -11.20 | 9.60 | -1.95 | -1.89 |
Net Changein Cash | -2.19 | -2.84 | 14.46 | 0.02 |
Cash Interest Paid | 0.69 | 1.23 | 0.67 | 1.27 |
Cash Taxes Paid | 2.41 | 9.50 | 1.53 | 2.25 |
Issuance( Retirement)of Stock Net | - | - | - | 0.00 |
Samrat Pharmachem Dividend Samrat Pharmachem Bonus Samrat Pharmachem News Samrat Pharmachem AGM Samrat Pharmachem Rights Samrat Pharmachem Splits Samrat Pharmachem Board Meetings Samrat Pharmachem Key Metrics Samrat Pharmachem Shareholdings Samrat Pharmachem Profit Loss Samrat Pharmachem Balance Sheet Samrat Pharmachem Q1 Results Samrat Pharmachem Q2 Results Samrat Pharmachem Q3 Results Samrat Pharmachem Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks